[The activization of an Ashkhabad focus of anthroponotic cutaneous leishmaniasis]

Insights

Anthroponotic cutaneous leishmaniasis (ACL) has reactivated in Ashkhabad, identified by Leishmania tropica strains and the vector Phlebotomus sergenti. This indicates a resurgence of a previously controlled disease focus.

Area of Science:

  • Medical Parasitology
  • Vector-borne Diseases
  • Epidemiology

Background:

  • Anthroponotic cutaneous leishmaniasis (ACL) is a significant public health concern.
  • Previous control efforts had aimed to sanitize foci of ACL in Ashkhabad.
  • The re-emergence of ACL necessitates updated surveillance and control strategies.

Observation:

  • Six patients presenting with characteristic ACL symptoms were identified in Ashkhabad between 1987 and 1988.
  • Isoenzymatic analysis of three Leishmania strains (MHOM/SU/87/392, MHOM/SU/87/393, MHOM/SU/87/410) confirmed them as Leishmania tropica.
  • Entomological surveys in Ashkhabad revealed the presence of the specific ACL vector, Phlebotomus sergenti, with an abundance index of 0.64-0.70.

Findings:

  • Isoenzymatic analysis confirmed the isolated Leishmania strains as Leishmania tropica, the causative agent of ACL.
  • The presence of the vector Phlebotomus sergenti, alongside clinical cases, establishes the transmission cycle.
  • The study identified 12 enzymes (G-6-PDH, PGM, 6-PGDH, ACP, ALP, PGI, GOT, ME, LDH, ALD, HK, FK) through electrophoresis for strain identification.

Implications:

  • The findings suggest a reactivation of a previously controlled ACL focus in Ashkhabad.
  • This highlights the importance of ongoing monitoring and integrated vector management in endemic areas.
  • Re-emergence of ACL poses a renewed threat to public health, requiring prompt intervention.

Related Concept Videos

Acid Mine Drainage01:19

Acid Mine Drainage

Mining activities that disturb sulfide-rich rocks, particularly those containing pyrite (FeS₂), initiate a cascade of geochemical and microbiological processes with serious environmental implications. When exposed to air and water, pyrite undergoes oxidation, releasing sulfate, ultimately forming sulfuric acid and mobilizing heavy metals into surrounding water systems. This phenomenon, known as acid mine drainage (AMD), results in low pH waters laden with toxic elements that threaten aquatic...
Inhalation Anthrax01:25

Inhalation Anthrax

Anthrax is a zoonotic disease caused by Bacillus anthracis, a Gram-positive, spore-forming bacterium. It primarily affects herbivorous animals but can be transmitted to humans through skin contact, ingestion, or inhalation of spores.Cutaneous anthrax, the most common form, typically results from direct contact with bacterial spores through skin abrasions and is generally less severe. Gastrointestinal anthrax results from eating undercooked or contaminated meat. It affects the mouth, throat, or...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...